PARIS, Feb. 13, 2025 (GLOBE NEWSWIRE) — PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its Series A financing with existing investor Pureos BioVentures committing new … Read More
News & Blog
AI-Driven Enhancements in ObvioGo 2.2 Redefine Efficiency, Compliance, and Innovation in Clinical Trial Management NEW YORK, Jan. 14, 2025 /PRNewswire/ — ObvioHealth, a global leader in digital clinical trial solutions, today announced the release of ObvioGo 2.2, the latest version of its innovative … Read More
Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401, in development for treatment-resistant or refractory rheumatoid arthritis (RA), as a one-time, curative treatment AURORA, CO, January 9, 2025 – RheumaGen, Inc., a cell and … Read More
Case Studies
Discover the insights from the consensus document on Latin America Acne Management, published by experts from SPRIM PRO. This pivotal research highlights how generational shifts are reshaping acne treatment needs, enabling healthcare professionals in Latin America to enhance care for patients. … Read More
A top US-based, multi-national oral care brand seeking to revamp its educational materials to better accommodate the evolving needs of a dental student population now primarily dominated by millennials. … Read More
A leading provider of high-quality, direct-to-consumer (DTC) dietary supplements sought out opportunities to build thought leadership in a rapidly growing market category. As competition increased via the introduction of mediocre players and formulas, a differentiation strategy that focused attention on the importance of quality was critical. … Read More
